Ac-Angiotensinogen (1-14), human
CAS No. 104180-27-0
Ac-Angiotensinogen (1-14), human( ——— )
Catalog No. M40861 CAS No. 104180-27-0
Acetyl angiotensinogen (1-14), human is a synthetic peptide and N-terminal acetylated form of Angiotensinogen (1-14), human.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAc-Angiotensinogen (1-14), human
-
NoteResearch use only, not for human use.
-
Brief DescriptionAcetyl angiotensinogen (1-14), human is a synthetic peptide and N-terminal acetylated form of Angiotensinogen (1-14), human.
-
DescriptionAcetyl angiotensinogen (1-14), human is a synthetic peptide and N-terminal acetylated form of Angiotensinogen (1-14), human.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number104180-27-0
-
Formula Weight1802.1
-
Molecular FormulaC85H124N24O20
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Crimmins DL, et, al. Peptide characterization with a sulfoethyl aspartamide column. J Chromatogr. 1988 Jun 29:443:63-71.?
molnova catalog
related products
-
(+)-JNJ-A07
(+)-JNJ-A07 is a pan-serotypic dengue virus inhibitor that targets NS3-NS4B interaction with high potency. (+)-JNJ-A07 has antiviral activity and can be used to study dengue virus infections.
-
Anantin (linear sequ...
Anantin binds competitively to the receptor of atrial natriuretic factor (ANF) from bovine adrenal cortex (Kd = 0.6 μM) and acts as natriuretic peptide receptor A antagonist.
-
pTH-Related Protein ...
pTH-Related Protein (67-86) amide (human, bovine, dog, mouse, ovine, rat)
Cart
sales@molnova.com